Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
APVO on Nasdaq
Shares outstanding
2,864,322
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
L1 Capital Global Opportunities Master Fund, Ltd. 7.6% +23% +$39,294 421,000 +110% L1 Capital Global Opportunities Master Fund, Ltd. 21 Apr 2025
BIGGER CAPITAL FUND L P 10% +62% 285,000 +42% BIGGER CAPITAL FUND L P 18 Jun 2025

Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$8 0
2024 Q4 0 $0 -$231,143 0
2024 Q3 1,283,310 $231,143 -$296,003 $0.18 17
2024 Q2 1,963,743 $599,087 +$598,269 $0.31 18
2024 Q1 2,643 $12,395 +$12,395 $4.69 10